Anaptys Biosciences has raised $33.9 million in its second venture round. The San Diego-based biotech garnered money from Novo A/S, Frazier Healthcare Ventures, Alloy Ventures, and Avalon Ventures. Much of that money will be put to use advancing the company's technology for antibody development and optimization.
- check out the release [1] for more
ALSO: Piedmont Pharmaceuticals has secured $8.5 million in Series B financing from CM Capital Investments of Brisbane, Australia, and other investors. Release [2]
PLUS: Cambridge, MA-based Ensemble Discovery, a developer of a DNA-programmed chemistry platform for developing therapeutics and bioassays, has raised $15 million in Series B funding. Report [3]
Related Article:
The Top 5 VC deals of the first half of 2007. Report [4]
Links:
[1] http://www.fiercebiotech.com/press-releases/press-release-anaptys-biosciences-raises-over-33-million-series-b-financing
[2] http://www.fiercebiotech.com/press-releases/press-release-piedmont-pharmaceuticals-secures-8-5-million-investment
[3] http://www.pehub.com/article/articledetail.php?articlepostid=8799
[4] http://www.fiercebiotech.com/special-reports/top-5-financing-deals-first-half-2007